Extracellular vesicles in fresh frozen plasma and cryoprecipitate: Impact on in vitro endothelial cell viability
Transfusion · 2024
DOI: 10.1111/trf.17959 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2024. Verfasst von Ji Hui Hwang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Plasma, Extracellular Vesicles, Cell Survival, Endothelial Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Australian Red Cross Lifeblood; Queensland University of Technology, Australian Government Research Training Program (RTP), Australian Governments.
Abstract (Originalsprache)
Background
Transfusion‐related acute lung injury (TRALI) remains a major contributor to transfusion‐associated mortality. While the pathogenesis of TRALI remains unclear, there is evidence of a role for blood components. We therefore investigated the potential effects of fresh frozen plasma (FFP), cryoprecipitate, and extracellular vesicles (EVs) derived from these blood components, on the viability of human lung microvascular endothelial cells (HLMVECs) in vitro.
Methods
EVs were isolated from FFP and cryoprecipitate using size‐exclusion chromatography and characterized by nanoparticle tracking analysis, western blotting, and transmission electron microscopy. The potential effects of these blood components and their EVs on HLMVEC viability (determined by trypan blue exclusion) were examined in the presence and absence of neutrophils, either with or without prior treatment of HLMVECs with LPS.
Results
EVs isolated from FFP and cryoprecipitate displayed morphological and biochemical properties conforming to latest international criteria. While FFP, cryoprecipitate, and EVs derived from FFP, each reduced HLMVEC viability, no effect was observed for EVs derived from cryoprecipitate.
Conclusion
Our findings demonstrate clear differences in the effects of FFP, cryoprecipitate, and their respective EVs on HLMVEC viability in vitro. Examination of the mechanisms underlying these differences may lead to an improved understanding of the factors that promote development of TRALI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.
- Strategy and Growth, Australian Red Cross Lifeblood, Brisbane, Queensland, Australia.
- Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
- School of Health, University of the Sunshine Coast, Sippy Downs, Queensland, Australia.
ORCID-Profile: Ji Hui Hwang, Natalie M Pecheniuk
Förderung
- Australian Red Cross Lifeblood; Queensland University of Technology
- Australian Government Research Training Program (RTP)
- Australian Governments
Zitieren
APA
Hwang, J. H., Tung, J. P., Harkin, D. G., Flower, R. L., & Pecheniuk, N. M. (2024). Extracellular vesicles in fresh frozen plasma and cryoprecipitate: Impact on in vitro endothelial cell viability. Transfusion. https://doi.org/10.1111/trf.17959
Vancouver
Hwang JH, Tung JP, Harkin DG, Flower RL, Pecheniuk NM. Extracellular vesicles in fresh frozen plasma and cryoprecipitate: Impact on in vitro endothelial cell viability. Transfusion. 2024. doi:10.1111/trf.17959
BibTeX
@article{Hwang2024,
author = {Hwang, Ji Hui and Tung, John-Paul and Harkin, Damien G and Flower, Robert L and Pecheniuk, Natalie M},
title = {Extracellular vesicles in fresh frozen plasma and cryoprecipitate: Impact on in vitro endothelial cell viability},
journal = {Transfusion},
year = {2024},
doi = {10.1111/trf.17959}
}
EUVIMED